Mandate August 07, 2026 Vinge advises Altor on its public offer for Sleep Cycle Snark BidCo, a company controlled by Altor Fund V (No. 1) and Altor Fund V (No. 2) announced a publi…
Mandate March 25, 2026 Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Mark…
Mandate March 03, 2026 Vinge has advised Oncopeptides in connection with its rights issue Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue whic…
